29 November 2022
Nestlé Press Release Ad hoc announcement pursuant to Art. 53 LR Follow today’s event live 0830 CET Investor webcast:https://edge.media-server.com/mmc/go/Nestle-Investor-Seminar-2022 Full details on our websitehttps://www.nestle.com/media/mediaeventscalendar/allevents/2022-nestle-investor-seminar…
Tuesday, 29 November 2022 2023 FULL-YEAR GUIDANCE Woodside has completed a review of its 2023 corporate plan, including cost, production and sales forecasts. As…
TREATT PLCFULL YEAR RESULTSYEAR ENDED 30 SEPTEMBER 2022 Strong platform for growth Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of…
29 November 2022 7:00 GMT AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy Acquisition provides access to next-generation T-cell receptor therapies…
28 November 2022
Accrol Group Hldgs Launch of second ESG Report RNS Number : 8140H Accrol Group Holdings PLC 28 November 2022 28 November 2022 Accrol Group…
C4X Discovery Holdings plc C4XD signs exclusive global licence worth up to $402 million1 with AstraZeneca for the development and commercialisation of NRF2 Activator programme…
28 November 2022 AIM: CER This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as…
25 November 2022
25 November 2022 SEQUOIA ECONOMIC INFRASTRUCTURE INCOME FUND LIMITED (the “Company” or “SEQI”) 2022 INTERIM RESULTS RESILIENT PERFORMANCE DESPITE CHALLENGING BACKDROP – TARGET DIVIDEND…